Hyponitrite Esters (i.e., Compounds Having The -o-n=n-o- Group Bonded Directly To Carbon, Which Carbon May Be Single Bonded To Any Atom But May Be Multiple Bonded Only To Carbon) Patents (Class 560/316)
Abstract: A compound of Formula (I): or a pharmaceutically acceptable salt of the compound. Also described are pharmaceutical formulations thereof and methods of using the same.
Type:
Grant
Filed:
November 8, 2013
Date of Patent:
May 5, 2015
Assignee:
Ironwood Pharmaceuticals, Inc.
Inventors:
Jeffrey Segal, Nisha Perez, Timothy Claude Barden
Abstract: This invention relates to novel compounds obtained by fermentation of Myxobacteria strain (PM0670013/MTCC 5570). The present invention further relates to the processes for the production of the novel anti-inflammatory compounds, to the culture no. PM0670013 (MTCC 5570), and to pharmaceutical compositions containing compounds of the present invention as an active ingredient and its use in medicines for the treatment of inflammatory diseases or disorders mediated by proinflammatory cytokines such as Tumor Necrosis Factor-alpha (TNF-?) and/or interleukins such as IL-6, having anti-inflammatory activity The invention also includes all stereoisomeric forms of compounds of the present invention.
Type:
Grant
Filed:
January 24, 2011
Date of Patent:
September 11, 2012
Assignee:
Piramal Healthcare Limited
Inventors:
Koteppa Pari, Girish Badrinath Mahajan, Nidhi Tomar, Vijaya Phani Kumar Yemparala, Asha Adrian Kulkarni-Almeida, Saji George